Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Prostate cancer screening in a healthy population cohort in eastern Nepal: an explanatory trial study.

Belbase NP, Agrawal CS, Pokharel PK, Agrawal S, Lamsal M, Shakya VC.

Asian Pac J Cancer Prev. 2013;14(5):2835-8.

2.

Prostate cancer screening in a Saudi population: an explanatory trial study.

Rabah DM, Arafa MA.

Prostate Cancer Prostatic Dis. 2010 Jun;13(2):191-4. doi: 10.1038/pcan.2009.60.

PMID:
20066007
3.
4.

Detection of prostate cancer in males with prostatism.

Lepor H, Owens RS, Rogenes V, Kuhn E.

Prostate. 1994 Sep;25(3):132-40.

PMID:
7520577
5.

Early diagnosis of prostate cancer in the Western Cape.

Heyns CF, Naudé AM, Visser AJ, Marais DC, Stopforth HB, Nyarko JK, Stellmacher GA.

S Afr Med J. 2001 Aug;91(8):679-84.

PMID:
11584784
6.

The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.

Palmerola R, Smith P, Elliot V, Reese CT, Mahon FB, Harpster LE, Icitovic N, Raman JD.

Can J Urol. 2012 Dec;19(6):6542-7.

PMID:
23228289
7.

Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.

Faria EF, Carvalhal GF, dos Reis RB, Tobias-Machado M, Vieira RA, Reis LO, Nogueira L, Machado RD, Freitas CH Jr, Magnabosco WJ, Mauad EC, Carvalho AL.

BJU Int. 2012 Dec;110(11 Pt B):E653-7. doi: 10.1111/j.1464-410X.2012.11398.x.

8.

Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.

Walsh AL, Considine SW, Thomas AZ, Lynch TH, Manecksha RP.

Br J Gen Pract. 2014 Dec;64(629):e783-7. doi: 10.3399/bjgp14X682861.

9.

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.

Törnblom M, Norming U, Adolfsson J, Becker C, Abrahamsson PA, Lilja H, Gustafsson O.

Urology. 1999 May;53(5):945-50.

PMID:
10223488
10.

Early detection of prostate cancer in the ESRD population.

Khairullah QT, Pamatmat SD, Chatha M, Provenzano R, Telang D, Temple M.

Clin Nephrol. 2004 May;61(5):308-15.

PMID:
15182125
11.
12.

Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.

Gosselaar C, Roobol MJ, van den Bergh RC, Wolters T, Schröder FH.

Eur Urol. 2009 Jan;55(1):139-46. doi: 10.1016/j.eururo.2008.03.079.

PMID:
18406045
13.

Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.

Men S, Cakar B, Conkbayir I, Hekimoglu B.

J Exp Clin Cancer Res. 2001 Dec;20(4):473-80.

PMID:
11876539
14.
15.

Screening of prostate cancer in males with prostatism.

Saxena S, Mohanty NK, Jain AK.

Indian J Pathol Microbiol. 1997 Oct;40(4):441-50.

PMID:
9444853
16.
17.

Digital rectal examination is barrier to population-based prostate cancer screening.

Nagler HM, Gerber EW, Homel P, Wagner JR, Norton J, Lebovitch S, Phillips JL.

Urology. 2005 Jun;65(6):1137-40.

PMID:
15922431
18.

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.

Candas B, Cusan L, Gomez JL, Diamond P, Suburu RE, Lévesque J, Brousseau G, Bélanger A, Labrie F.

Prostate. 2000 Sep 15;45(1):19-35.

PMID:
10960839
20.

Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.

Luboldt HJ, Bex A, Swoboda A, Hüsing J, Rübben H; Early Detection Project Group of the German Urological Association..

Eur Urol. 2001 Feb;39(2):131-7.

PMID:
11223671
Items per page

Supplemental Content

Support Center